Home / Market News / $ALL
benzinga Corporate Catalyst Impact 55/100 ● negative

Barclays Maintains Underweight on Allstate, Lowers Price Target to $221

Oct 7, 2026, 1:27 PM UTC · Primary ticker $ALL

Barclays analyst Alex Scott has reiterated an 'Underweight' rating on Allstate and slightly reduced its price target from $226 to $221. This indicates a continued cautious outlook from Barclays on Allstate's stock performance, which could exert minor downward pressure on the stock.

Barclays analyst Alex Scott maintained an 'Underweight' rating on Allstate and lowered the price target from $226 to $221. This action signals a continued bearish stance from Barclays on Allstate's future stock performance. For traders, this could translate into short-term negative sentiment, potentially leading to some selling pressure on ALL shares. The long-term implications depend on whether other analysts follow suit or if Allstate's fundamentals change significantly. A key risk for traders is that this analyst downgrade, while minor, could contribute to a broader negative perception if not offset by positive company news.

$ALL negative Price target lowered, Underweight rating maintained
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.